• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease.

作者信息

Busca Alessandro, Locatelli Franco, Marmont Filippo, Audisio Ernesta, Falda Michele

出版信息

Haematologica. 2003 Jul;88(7):837-9.

PMID:12857569
Abstract
摘要

相似文献

1
Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease.霉酚酸酯治疗难治性慢性移植物抗宿主病的疗效
Haematologica. 2003 Jul;88(7):837-9.
2
Mycophenolate mofetil (MMF) for refractory chronic graft versus host disease (cGvHD).霉酚酸酯（MMF）用于治疗难治性慢性移植物抗宿主病（cGvHD）。
Haematologica. 2003 Aug;88(8):ELT28; author reply ELT29.
3
Decreased risk of acute gastrointestinal toxicity when substituting methotrexate with mycophenolate mofetil in the prevention of graft-versus-host disease in stem cell transplantation following myeloablative conditioning regimens.在清髓性预处理方案后的干细胞移植中，用霉酚酸酯替代甲氨蝶呤预防移植物抗宿主病时，急性胃肠道毒性风险降低。
Bone Marrow Transplant. 2006 Jan;37(2):235-6; author reply 236-7. doi: 10.1038/sj.bmt.1705227.
4
Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.霉酚酸酯治疗骨髓移植受者急慢性移植物抗宿主病的疗效和安全性。
Transplant Proc. 1998 Dec;30(8):4087-9. doi: 10.1016/s0041-1345(98)01351-7.
5
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation.一项前瞻性随机试验的长期随访，该试验比较了环孢素A（CYA）联合甲氨蝶呤（MTX）与CYA联合霉酚酸酯用于清髓性同胞供者造血细胞移植中预防移植物抗宿主病（GVHD）的效果。
Bone Marrow Transplant. 2013 Nov;48(12):1578-80. doi: 10.1038/bmt.2013.89. Epub 2013 Jun 10.
6
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.霉酚酸酯用于治疗造血干细胞移植患者的急慢性移植物抗宿主病：四年经验
Transplant Proc. 2001 May;33(3):2121-3. doi: 10.1016/s0041-1345(01)01968-6.
7
Maximizing the benefits of mycophenolate mofetil as graft-versus-host disease prophylaxis.最大限度发挥霉酚酸酯在预防移植物抗宿主病方面的益处。
Biol Blood Marrow Transplant. 2014 Nov;20(11):1869-70. doi: 10.1016/j.bbmt.2014.07.023. Epub 2014 Jul 25.
8
Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus.在一名对环孢素和他克莫司过敏的异基因造血干细胞移植受者中，使用静脉注射霉酚酸酯预防移植物抗宿主病。
Bone Marrow Transplant. 2006 Aug;38(3):253-4. doi: 10.1038/sj.bmt.1705422. Epub 2006 Jun 19.
9
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].霉酚酸酯联合环孢素A和甲氨蝶呤预防异基因外周血干细胞移植中急性移植物抗宿主病
Zhonghua Yi Xue Za Zhi. 2002 Apr 25;82(8):507-10.
10
Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.霉酚酸酯仅对异基因造血干细胞移植后类固醇难治性急性移植物抗宿主病累及的皮肤有效。
Ann Hematol. 2017 Feb;96(2):319-321. doi: 10.1007/s00277-016-2854-0. Epub 2016 Oct 21.

引用本文的文献

1
[Chinese expert consensus on the diagnosis and treatment of chronic graft-versus-host disease (2024)].《慢性移植物抗宿主病诊断与治疗中国专家共识（2024年版）》
Zhonghua Xue Ye Xue Za Zhi. 2024 Aug 14;45(8):713-726. doi: 10.3760/cma.j.cn121090-20240611-00217.
2
[Chinese consensus on the diagnosis and management of chronic graft-versus-host disease (2021)].《慢性移植物抗宿主病诊断与治疗中国专家共识（2021年版）》
Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):265-275. doi: 10.3760/cma.j.issn.0253-2727.2021.04.001.
3
Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
造血细胞移植后眼移植物抗宿主病：来自 CIBMTR 晚期效应和生活质量工作组以及 EBMT 移植并发症工作组的专家综述。
Bone Marrow Transplant. 2019 May;54(5):662-673. doi: 10.1038/s41409-018-0340-0. Epub 2018 Dec 7.
4
Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.造血细胞移植后眼移植物抗宿主病：来自国际血液和骨髓移植研究中心晚期效应和生活质量工作组以及欧洲血液和骨髓移植学会移植并发症工作组的专家综述。
Biol Blood Marrow Transplant. 2019 Feb;25(2):e46-e54. doi: 10.1016/j.bbmt.2018.11.021. Epub 2018 Nov 24.
5
Treatment and management of graft-versus-host disease: improving response and survival.移植物抗宿主病的治疗与管理：改善反应与生存
Ther Adv Hematol. 2013 Dec;4(6):366-78. doi: 10.1177/2040620713489842.
6
Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.慢性移植物抗宿主病患者的临床医生反应评分与计算反应测量之间的一致性较差。
Biol Blood Marrow Transplant. 2012 Nov;18(11):1649-55. doi: 10.1016/j.bbmt.2012.05.005. Epub 2012 Jun 9.
7
Mycophenolate mofetil: fully utilizing its benefits for GvHD prophylaxis.霉酚酸酯：充分利用其预防移植物抗宿主病的益处。
Int J Hematol. 2012 Jul;96(1):10-25. doi: 10.1007/s12185-012-1086-x. Epub 2012 May 17.
8
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside.慢性移植物抗宿主病中的酪氨酸激酶抑制剂：从实验台到临床应用
ScientificWorldJournal. 2011;11:1908-31. doi: 10.1100/2011/924954. Epub 2011 Oct 25.
9
Treatment of chronic graft-versus-host disease: Past, present and future.慢性移植物抗宿主病的治疗：过去、现在与未来。
Korean J Hematol. 2011 Sep;46(3):153-63. doi: 10.5045/kjh.2011.46.3.153. Epub 2011 Sep 30.
10
The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma.慢性移植物抗宿主病的病理生理学：揭开一个谜团。
Korean J Hematol. 2011 Jun;46(2):80-7. doi: 10.5045/kjh.2011.46.2.80. Epub 2011 Jun 21.